Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
The blood coagulation cascade is an exquisite example of a responsive self-assembly process. When a wound if formed, a cascade of events is initiated. The net result of the cascade is an assembly of the globular protein fibrinogen, which is catalyzed by a second protein, thrombin, to
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
The blood coagulation cascade is an exquisite example of a responsive self-assembly process. When a wound if formed, a cascade of events is initiated. The net result of the cascade is an assembly of the globular protein fibrinogen, which is catalyzed by a second protein, thrombin, to
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
A wide variety of compositions and devices have been developed for use in controlling bleeding. However, available compositions and dressings typically have only a modest hemostatic effect, so that bleeding continues for several (e.g., 2-3 minutes or more) after application of composition
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
A wide variety of compositions and devices have been developed for use in controlling bleeding. However, available compositions and dressings typically have only a modest hemostatic effect, so that bleeding continues for several (e.g., 2-3 minutes or more) after application of composition
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This invention relates to mouthcare-products such as toothpastes, mouth rinsing liquids and medicinal mouthcare-compositions.
Well known toothpastes (as a paste, liquid form or as a powder form), mouth rinsing liquids (mouthwashes) and medicinal mouthcare preparations (e.g. preparations for
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
This disclosure relates to methods and compositions to stop bleeding, and specifically to a composition comprising a hemostatic active ingredient and an astringent ingredient for clotting blood.
BACKGROUND
Approximately 90 million people in the United States have a nosebleed in their lifetime
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD
This disclosure relates to methods and compositions to stop bleeding, and specifically to a composition comprising a hemostatic active ingredient and an astringent ingredient for clotting blood.
BACKGROUND
Approximately 90 million people in the United States have a nosebleed in their lifetime
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
Fungerar på 55 språk
Växtbaserade botemedel som stöds av vetenskap
Örter igenkänning av bild
Interaktiv GPS-karta - märka örter på plats (kommer snart)
Läs vetenskapliga publikationer relaterade till din sökning
Sök efter medicinska örter efter deras effekter
Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot. * All information baseras på publicerad vetenskaplig forskning